Pliant Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Pliant Therapeutics

09/05/2023 23:18

* Pliant Therapeutics Inc  PLRX.OQ  reported a quarterly
adjusted
loss of 67 cents​​ per share for the quarter ended in March. The
mean expectation of twelve analysts for the quarter was for a
loss of 67 cents per share.
    * Revenue rose 6.6% to $1.33 million from a year ago;
analysts
expected $1.21 million. 
    * Pliant Therapeutics Inc's reported EPS for the quarter was
a
loss of 67 cents​.
    * The mean earnings estimate of analysts had risen by
about 5.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Pliant Therapeutics Inc shares had fallen by 16.9% this
quarter and gained 14.3% so far this year.
    * The company reported a quarterly loss of $37.55 million.
    * Wall Street's median 12-month price target for Pliant
Therapeutics Inc is $45.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
9 at 10:18 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.67          -0.67          Met
 Dec. 31 2022      -0.70          -0.72          Missed
 Sep. 30 2022      -0.74          -0.65          Beat
 Jun. 30 2022      -0.81          -0.82          Missed